Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rebought this one at .0038 and sold at .0063 yesterday Should have held a few but happy with the gains. This still might have lots of room to go up
my_os now @ .30, steady climber
someone is dropping a nice chunk of change on this today
better than me with 0, lol. Hopefully not for long though...got a few bids sprinkled in there.
pr_of more huge bids at .25
Nice bid @ .03
very nice, thinking about throwing a bid in. gonna watch a bit more. g/l
you get into this one pre-split? Nice action today
yeah, I'm done there as well. However, I did get some sn_py the other day on the bid at .022 just for fun and a quick flip. Ahhh memories.
That seems to be the rumor floating around. If that thing hits a buck, several people on this board might be on suicide watch.
exactly, hard to watch it go higher but this one was very good to me as well. Ok, back to trying to ignore it :)
Just some interesting buying today and good news released over the last couple weeks. I didn't buy much and there's a decent chance I'm late to the party but we'll see.
my_os in for a few at .205
sure looks that way...in for a few
more .001's on ask again....
back in for a few @ .0018, bid looking good now
I don't think I'm any closer to an answer than you are...very odd deal and then in the Disclosure statement under Buisness Development it says:
Just read it...interesting
Nice, good to see them go into good hands. I hope there are some around at the end of the week when some funds become available. Good luck.
.15's available again, would grab some but im tapped out
Got 50K of them...
Just missed them...damn
sounds great...always appreciate your dd Brother
ja_qc in at .15
I looked at it a while back but haven't paid too much attention. Todays action looks very interesting, VERT sitting on a big bid. Watching now :)
I hear ya guys, my screen has not looked good for a while now. Heres hoping its just a temporary thing...good luck everyone
Dropped the "D" today
That really is the only way to get anything on that one. The bid is impossible. Most tightly held stock I've seen on here. g/l
same but busted as well. Lots of red on my screen and little cash today. That paint on zp_cm at least made the account look ok ;)
Yeah, for my own sanity I try not too watch it ;) My first buy was at .50 and then when the big mailer came out around 1.00, it looked poised for a major dump. Still did ok on it but sure wish I held on to a few...
Welcome GM
lol, teamwork at its finest
saw that hit and wondered if that might be you ;), hope it fills for you
Grabbed some .0012 yesterday on your call dijeetyet, nice work and good luck
ms_he... moves super easy, possible merger coming. Kind of an interesting one to keep on watch.
Still can't believe how few shares are on the bid/ask. For a low .00 stock, this thing has a fraction of the trading that others do. Any kind of catalyst (news, filings, etc) and MSHE could explode. Holding.
grabbed a few here today, trades super thin for a .00
Harbinger Research Releases Research Report on Vycor Medical, Inc.
Vycor Med (OTCBB:VYCO)
Today : Tuesday 1 May 2012
Vycor Medical, Inc. (OTCBB: VYCO), a Florida-based corporation, is pleased to announce today that Harbinger Research has released a new comprehensive report regarding its analysis of the Company and its two subsidiaries. The report can be accessed on the Harbinger Research website directly at http://www.harbingerresearch.com/clients/vyco.
The report states that Harbinger Research "are initiating coverage of Vycor with a Strong Buy rating and a target price range of $0.05 per share" noting that Vycor's neurosurgical ViewSite Brain Access System leads to "improved clinical outcomes, shorter surgeries, and shorter recovery times; in some cases this product's superior attributes have allowed brain surgeons to successfully perform surgeries that would have otherwise been considered inoperable" and that they are "most excited about the long-term potential of the NovaVision subsidiary, as its products have no real competition and address a global market that could be up to $20B in size." Furthermore they state that "both NovaVision and ViewSite have strong patent protection and backing from the scientific community, and both are FDA 510(k) cleared for sale in the United States."
David Cantor, President of Vycor Medical, stated that management is pleased by the positive outlook for the Company reflected in the report.
About Vycor Medical Inc.:
With corporate headquarters in Boca Raton, FL, Vycor Medical, Inc. (OTCBB: VYCO) is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. The company's flagship, Patent Pending ViewSite™ Surgical Access Systems represent an exciting new minimally invasive access and retraction system that holds the potential for speedier, safer and more economical brain, spinal and other surgeries and a quicker patient discharge. Vycor's innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. Vycor is ISO 13485:2003 compliant, has FDA 510(k) clearance for brain and spine surgeries, and CE Marking and HPB licensing in Canada.
Vycor Medical's subsidiary, NovaVision, Inc., researches, develops and provides science-driven vision-based neurostimulation therapy and other medical technologies that help to improve sight in patients with neurological vision impairments. The company's proprietary, Visual Restoration Therapy (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury ("TBI"), or other acquired brain injury, and has been 510(k) cleared to be marketed in the US by the FDA. VRT can be prescribed by any ophthalmologist, optometrist, neurologist or physiatrist. NovaVision, through its subsidiary Sight Science, also provides Neuro-Eye Therapy (NeET), aimed at increasing visual sensitivity deep within the field defect. NovaVision also provides a fully portable and ADA-compliant Head Mounted Perimeter (HMP™) which aids in the detection and measurement of visual field deficits
For the latest information on the company, including media and other coverage, and to learn more, please go online at www.vycormedical.com or www.novavision.com.
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Vycor Medical's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Vycor Medical's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Vycor Medical herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Vycor Medical disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
Lenny Sorin
Vycor Medical, Inc.
561-558-2000
joined ya at .03 g/l
More NEWS:
Yakun International Announces Opening of 2 New Stores
Yakun International Holding & Investment Group (YIHG.PK), a leading manufacturer and distributor of authentic Chinese bakery products in the Northeastern region of China, today announced that in April it opened two new stores in Songyuan City, Jilin Province. The stores were opened under the Company’s “DingFengZhen” brand name, a Time Honored brand in China. These are the 2nd and 3rd retail shops opened by the Company in Songyuan City. The Company entered the Songyuan market when it opened its flagship store in Songyuan six months ago.
Songyuan City is situated in the west-central area of Jilin Province, adjacent to Changchun. It borders Inner Mongolia to the west and to the north is separated from Heilongjiang by the Songhua, Nenjiang and Lalin rivers. The annual GDP and per capita GDP in Songyuan City rank third among all the cities in Jilin Province. China’s 6th largest onshore oil field is located in Songyuan City, and the City has the highest rate of GDP growth among all the cities in the Northeastern area of China.
A key component of the Company’s marketing strategy is to open more retail stores in different areas of Changchun and other cities in Jilin Province. At the end of 2011, the Company had 13 retail stores totaling approximately 1,800 square meters. The Company plan to open an additional 15 retail stores in 2012 totaling at least 2,100 square meters.
Our “Qianjin Shop” and “Platinum Shop” were opened on April 21st and April 29th, 2012, respectively. The Qianjin Shop located in the North River business district occupies 150 sq. meters, while our Platinum Shop located in the South River Business District has 230 sq. meters. Each store is equipped with advanced baking equipment to ensure consistent flavors and quality. Each store contains an on-site cooking area, decoration room, service area and waiting area for customers. The stores offer traditional Chinese bakery products and western styled products, along with beverages, including milk and specialty teas, coffees, and fruit juices.
“2012 is a critical year for us. Our main focus is to open more retail stores and optimize the operation of all stores,” said Baotian Xie, the Chief Operating Officer of Yakun International. He continued stating that “the implementation of our marketing strategy through opening a chain of stores will both enhance our brand awareness and solidify our dominant position in the Chinese bakery industry in Jilin Province.”
About Yakun International
Yakun International, through its wholly owned entity, Changchun Decens, is one of the largest manufacturers and distributors of bakery products in Jilin Province, China. Under “DingFengZhen”, a China Time Honored Brand established in 1911, the Company sells bakery products through various channels including its wholly owned retail stores, supermarkets, smaller chain supermarkets and convenience stores located throughout Jilin. In addition to a large variety of traditional Chinese holiday bakery products, including moon cakes, rice glue balls and zong-zi, the Company also offers western-style breads, cookies, cakes and pastries.
Forward-Looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions, and statements that are other than statements of facts. These statements are subject to uncertainties and risks including, but not limited to, product demand, changes in consumer tastes, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements contained herein are expressly qualified by this cautionary statement and any cautionary statements contained in the Company’s filings. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.